ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era?

Ann Surg Oncol. 2020 Apr;27(4):1189-1190. doi: 10.1245/s10434-020-08201-6. Epub 2020 Jan 17.

Authors

Danielle M Bello¹, Charlotte E Ariyan²

Affiliations

¹ Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [email protected].
² Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 31953700
DOI: 10.1245/s10434-020-08201-6

No abstract available

MeSH terms

Combined Modality Therapy
Humans
Immune Checkpoint Inhibitors / therapeutic use*
Melanoma / drug therapy*
Melanoma / pathology
Melanoma / surgery*
Metastasectomy*
Progression-Free Survival
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Skin Neoplasms / surgery*

Substances

Immune Checkpoint Inhibitors